✦ LIBER ✦

Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer’s and Parkinson’s diseases

✍ Scribed by Ilan Halperin; Micaela Morelli; Amos D. Korczyn; Moussa B.H. Youdim; Silvia A. Mandel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CNS Targets for multi-functional drugs i

✍ M. B. H. Youdim; J. J. Buccafusco 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 350 KB

Biomarker candidates of neurodegeneratio

✍ Manfred Gerlach; Walter Maetzler; Karl Broich; Harald Hampel; Lucas Rems; Torste 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 246 KB

Evidence of shared risk for Alzheimer’s

✍ Ami R. Rosen; N. Kyle Steenland; John Hanfelt; Stewart A. Factor; James J. Lah; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 153 KB

Progress in the development of new treat

✍ Eliezer Masliah; Lawrence A. Hansen; Edward Rockenstein; Makoto Hashimoto 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

Toward the Validation of Functional Neur

✍ Alberto Pupi; Lisa Mosconi; Flavio M. Nobili; Sandro Sorbi 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 215 KB

Cognitive evaluation of disease-modifyin

✍ Debby Van Dam; Katrien Coen; Peter Paul De Deyn 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 159 KB